UCB is a global biopharma focused on severe diseases in two therapeutic areas: central nervous system and immunology operations.
The company is listed on the Euronext Brussels Stock Exchange and has its headquarters in Brussels, Belgium. It employs more than 8,500 people in more than 40 countries.
Financial Data
-
31st Dec 18 Source: CRO
- €36.9 million turnover
-
€25.8 million
profit - 1 employees
-
31st Dec 17 Source: CRO
- €163 million turnover
-
€12.2 million
profit - 1 employees
- 10 more years available »
Ranking
By Turnover
(€36.9 million)- 764th in Top Companies
- 89th in Health
- 77th in Pharma
By Employees
(1)- 990th in Top Companies
- 97th in Health
- 84th in Pharma
-
- 1
- €36.9 million
Employees
- Steve Turley CEO/Managing Director
Latest News
- 6:30am Restaurants seek rent help, QIH lays off 600 staff, and podcasts playing a blinder
- 5:00am Healthcare workers get a lift with free ebikes ahead of scheme launch
- 5:00am Restaurateurs seeking deals on rent with many payments due this week
- 4:00am Drone delivery start-up Manna says crisis shows importance of technology
- 12:13am Air New Zealand to lay off 3,500 staff as coronavirus stunts travel